Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors.
(2005) Gynecologic Oncology — Vol. 97, n° 1, p. 266-270 (2005)
Files
Mateo-2005-Optimalcytoreductionaftercombined.pdf
Restricted Access - Adobe PDF
- 331.27 KB
Details
- Authors
- Abstract
- BACKGROUND: The role of radiofrequency ablation (RFA) in the treatment of hepatic metastases from recurrent ovarian tumors is undefined. CASE: Three patients with hepatic lesions from recurrent ovarian cancers underwent a combined partial hepatectomy with radiofrequency ablation (RFA) to achieve optimal tumor cytoreduction. Follow-up radiological studies as well as serial tumor markers are consistent with disease-free survival after 39, 13, and 9 months. CONCLUSION: These results demonstrate the feasibility and safety of RFA for metastatic ovarian lesions to the liver in patients previously deemed as poor or non-surgical candidates, and suggest the potential for improvement in survival over unresected patients or in patients resected with residual disease.
- Affiliations
Keck School of Medicine, University of Southern California, University Hospital, Los Angeles (USA) Division of Hepatobiliary/Pancreatic Surgery and Abdominal Organ Transplantation
Citations
Mateo, R., Singh, G., Jabbour, N., Palmer, S., Genyk, Y., & Roman, L. (2005). Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecologic Oncology, 97(1), 266-270. https://doi.org/10.1016/j.ygyno.2004.12.038 (Original work published 2005)